688177 百奥泰
盘后交易 07-23 15:00:00
资讯
新帖
简况
百奥泰大跌5.02% 北向资金减持13.28万股
智选洞察 · 09:57
百奥泰大跌5.02% 北向资金减持13.28万股
【机构调研记录】浙商基金调研卫星化学、百奥泰等4只个股（附名单）
证券之星 · 07-22 08:02
【机构调研记录】浙商基金调研卫星化学、百奥泰等4只个股（附名单）
百奥泰(688177.SH)：BAT2206(乌司奴单抗)注射液上市许可申请获美国FDA和欧洲EMA受理
智通财经 · 07-19
百奥泰(688177.SH)：BAT2206(乌司奴单抗)注射液上市许可申请获美国FDA和欧洲EMA受理
百奥泰：BAT2206注射液上市许可申请获美国FDA和欧洲EMA受理
国际金融报 · 07-19
百奥泰：BAT2206注射液上市许可申请获美国FDA和欧洲EMA受理
百奥泰（688177）7月18日主力资金净买入220.28万元
证券之星 · 07-19
百奥泰（688177）7月18日主力资金净买入220.28万元
百奥泰07月18日主力资金流入231万元 连续7日加仓
自选股智能写手 · 07-18
百奥泰07月18日主力资金流入231万元 连续7日加仓
7月17日百奥泰涨8.00%，富国医疗保健行业混合A基金重仓该股
证券之星 · 07-17
7月17日百奥泰涨8.00%，富国医疗保健行业混合A基金重仓该股
超跌及地产政策空窗期是科技行业短周期的以反弹的两个重要条件，科创100ETF(588190)跟踪指数走势占优，微导纳米、芯源微、百奥泰领涨。
和讯网 · 07-17
超跌及地产政策空窗期是科技行业短周期的以反弹的两个重要条件，科创100ETF(588190)跟踪指数走势占优，微导纳米、芯源微、百奥泰领涨。
国内制药企业迎来新一轮创新产品周期，创新药ETF(159992)实时成交额突破2.08亿元，百奥泰、万泰生物、迪哲医药-U领涨。
和讯网 · 07-17
国内制药企业迎来新一轮创新产品周期，创新药ETF(159992)实时成交额突破2.08亿元，百奥泰、万泰生物、迪哲医药-U领涨。
单抗概念盘中拉升，百奥泰涨4.24%
自选股智能写手 · 07-17
单抗概念盘中拉升，百奥泰涨4.24%
百奥泰大幅上涨 获北向资金减持2.16万股
智选洞察 · 07-17
百奥泰大幅上涨 获北向资金减持2.16万股
百奥泰07月16日主力资金流入235万元 连续5日加仓
自选股智能写手 · 07-16
百奥泰07月16日主力资金流入235万元 连续5日加仓
百奥泰（688177）7月15日主力资金净买入139.16万元
证券之星 · 07-16
百奥泰（688177）7月15日主力资金净买入139.16万元
百奥泰07月12日主力资金流入521万元 连续3日加仓
自选股智能写手 · 07-12
百奥泰07月12日主力资金流入521万元 连续3日加仓
7月11日百奥泰涨5.04%，富国医疗保健行业混合A基金重仓该股
证券之星 · 07-11
7月11日百奥泰涨5.04%，富国医疗保健行业混合A基金重仓该股
百奥泰涨5.04%，太平洋二个月前给出“买入”评级
证券之星 · 07-11
百奥泰涨5.04%，太平洋二个月前给出“买入”评级
百奥泰大幅上涨 获北向资金增持2.00万股
智选洞察 · 07-11
百奥泰大幅上涨 获北向资金增持2.00万股
百奥泰（688177）7月9日主力资金净卖出926.21万元
证券之星 · 07-10
百奥泰（688177）7月9日主力资金净卖出926.21万元
百奥泰07月09日遭主力抛售803万元 环比增加243.16%
自选股智能写手 · 07-09
百奥泰07月09日遭主力抛售803万元 环比增加243.16%
7月8日百奥泰跌5.94%，富国医疗保健行业混合A基金重仓该股
证券之星 · 07-08
7月8日百奥泰跌5.94%，富国医疗保健行业混合A基金重仓该股
加载更多
公司概况
公司名称：
百奥泰生物制药股份有限公司
所属行业：
医药制造业
上市日期：
2020-02-21
主营业务：
百奥泰生物制药股份有限公司的主营业务是药物的研发、生产和销售。公司的主要产品是创新药和生物类似药，用于治疗肿瘤、自身免疫性疾病、心血管疾病以及其它危及人类生命或健康的重大疾病。
发行价格：
32.76
{"stockData":{"symbol":"688177","market":"SH","secType":"STK","nameCN":"百奥泰","latestPrice":20.32,"timestamp":1721718000000,"preClose":21.7,"halted":0,"volume":2406426,"delay":0,"floatShares":413999999,"shares":413999999,"eps":-0.8958,"marketStatus":"盘后交易","marketStatusCode":4,"change":-1.38,"latestTime":"07-23 15:00:00","open":21.7,"high":21.9,"low":20.32,"amount":49835500,"amplitude":0.0728,"askPrice":20.32,"askSize":33,"bidPrice":20.31,"bidSize":14,"shortable":0,"etf":0,"ttmEps":-0.8958,"tradingStatus":3,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721784600000},"adr":0,"adjPreClose":21.7,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721698200000,1721705400000],[1721710800000,1721718000000]],"highLimit":23.87,"lowLimit":19.53,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":414080000,"pbRate":7.69,"roa":"--","roe":"--","epsLYR":-0.95,"committee":-0.255814,"marketValue":8414000000,"floatMarketCap":8414000000,"peRate":-22.683635,"changeRate":-0.0636,"turnoverRate":0.0058,"status":1,"afterMarket":{"amount":0,"volume":0,"close":20.32,"buyVolume":0,"sellVolume":0,"time":1721718981154,"indexStatus":"盘后交易 07-23 15:16:21","preClose":21.7}},"requestUrl":"/m/hq/s/688177","defaultTab":"news","newsList":[{"id":"2453972212","title":"百奥泰大跌5.02% 北向资金减持13.28万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453972212","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453972212?lang=zh_cn&edition=full","pubTime":"2024-07-23 09:57","pubTimestamp":1721699828,"startTime":"0","endTime":"0","summary":"07月23日，百奥泰股价大幅下跌，截至09点57分，百奥泰下跌5.02%，报20.61元/股，成交1533万元，换手率0.18%，振幅5.94%。资金动向截止发稿，百奥泰获得主力净流入28万元，其中超大单流出50万元，大单流入78万元。北向资金方面，百奥泰07月22日获得北向资金减持13.28万股，截至07月22日，北向资金当前共持有百奥泰307.82万股，市值6344万元，持股占流通股比为0.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723095723aefadea7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723095723aefadea7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2453787201","title":"【机构调研记录】浙商基金调研卫星化学、百奥泰等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2453787201","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453787201?lang=zh_cn&edition=full","pubTime":"2024-07-22 08:02","pubTimestamp":1721606550,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月19日披露的机构调研信息，浙商基金近期对4家上市公司进行了调研，相关名单如下：1）卫星化学 个股亮点：公司主营产品中包括聚醚大单体；公司有绿色新材料产业园项目；公司自主研发α-烯烃，解决POE原料限制2）百奥泰 个股亮点：公司的主营业务是创新药和生物类似药的研发、生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200001629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002648","688177","BK0028","BK0239","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2580892789.USD","LU2580892862.HKD","BK0070","BK0186","BK0197","BK0229","IE00B5MMRT66.SGD","BK0188"],"gpt_icon":0},{"id":"2452494514","title":"百奥泰(688177.SH)：BAT2206(乌司奴单抗)注射液上市许可申请获美国FDA和欧洲EMA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2452494514","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452494514?lang=zh_cn&edition=full","pubTime":"2024-07-19 16:27","pubTimestamp":1721377647,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥泰 公告，公司向美国食品药品监督管理局和欧洲药品管理局递交了BAT2206注射液的生物制品上市申请，并于近日收到了美国FDA和欧洲EMA受理的通知。BAT2206注射液是百奥泰根据国家药品监督管理局、美国FDA、欧洲EMA生物类似药相关指导原则开发的乌司奴单抗注射液，乌司奴单抗是一款靶向白细胞介素IL-12和IL-23共有的p40亚基的全人源单克隆抗体。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2452449762","title":"百奥泰：BAT2206注射液上市许可申请获美国FDA和欧洲EMA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2452449762","media":"国际金融报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452449762?lang=zh_cn&edition=full","pubTime":"2024-07-19 16:26","pubTimestamp":1721377580,"startTime":"0","endTime":"0","summary":"百奥泰公告，公司向美国FDA和欧洲EMA递交了BAT2206注射液的生物制品上市申请，近日收到受理通知。该药品为乌司奴单抗注射液，已在全球多区域开展商业化进程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719162623af93211b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719162623af93211b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2452642174","title":"百奥泰（688177）7月18日主力资金净买入220.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452642174","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452642174?lang=zh_cn&edition=full","pubTime":"2024-07-19 08:23","pubTimestamp":1721348634,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月18日收盘，百奥泰报收于21.68元，下跌2.08%，换手率0.87%，成交量3.61万手，成交额7802.8万元。近5日资金流向一览见下表：百奥泰融资融券信息显示，融资方面，当日融资买入467.86万元，融资偿还823.65万元，融资净偿还355.79万元。百奥泰主营业务：创新药和生物类似药的研发、生产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071900013663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2452017682","title":"百奥泰07月18日主力资金流入231万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2452017682","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452017682?lang=zh_cn&edition=full","pubTime":"2024-07-18 15:19","pubTimestamp":1721287197,"startTime":"0","endTime":"0","summary":"07月18日, 百奥泰股价跌2.08%，报收21.68元，成交金额7802万元，换手率0.87%，振幅4.02%，量比1.47。百奥泰今日主力资金净流入231万元，连续7日净流入，上一交易日主力净流入201万元，今日环比增加14.93%。该股近5个交易日上涨3.04%，主力资金累计净流入1351万元，其中3个交易日为股价下跌时净流入；近20日主力资金累计净流出236万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071815403395d3f584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071815403395d3f584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2452182703","title":"7月17日百奥泰涨8.00%，富国医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452182703","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452182703?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:21","pubTimestamp":1721204478,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日百奥泰涨8.00%，收盘报22.14元，换手率0.97%，成交量4.0万手，成交额8703.72万元。重仓百奥泰的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家；过去90天内机构目标均价为35.52。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为富国医疗保健行业混合A。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700032589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2452518973","title":"超跌及地产政策空窗期是科技行业短周期的以反弹的两个重要条件，科创100ETF(588190)跟踪指数走势占优，微导纳米、芯源微、百奥泰领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452518973","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452518973?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:52","pubTimestamp":1721195556,"startTime":"0","endTime":"0","summary":"2024年7月17日，科创100指数大幅上涨。盘面上，微导纳米领涨，芯源微、百奥泰跟涨，科创100ETF市场热度较高，过去20个交易日日均成交额达到1.30亿元。随着7月重要会议的临近，这些预期有望进一步强化，从而提振市场情绪。大级别地产政策的推出时间间隔较为固定，每轮大规模地产政策推出的时间间隔大约在9-10个月左右。相关产品： 科创100ETF以上内容与数据，与界面有连云频道立场无关，不构成投资建议。据此操作，风险自担。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071715284095cd36a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071715284095cd36a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177","588190","BK0251","688037","688147"],"gpt_icon":0},{"id":"2452018608","title":"国内制药企业迎来新一轮创新产品周期，创新药ETF(159992)实时成交额突破2.08亿元，百奥泰、万泰生物、迪哲医药-U领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452018608","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452018608?lang=zh_cn&edition=full","pubTime":"2024-07-17 13:29","pubTimestamp":1721194186,"startTime":"0","endTime":"0","summary":"盘面上，百奥泰领涨，万泰生物、迪哲医药-U跟涨，创新药ETF市场热度较高，过去10个交易日日均成交额达到2.22亿元。广发证券表示，国内制药企业将迎来新一轮创新产品周期。2023年CDE承办新药临床开发项目超过760项，新药首次上市申报达到110项。据此操作，风险自担。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071715304195cd3880&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071715304195cd3880&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688177","BK0239","603392","515120","688192","159992"],"gpt_icon":0},{"id":"2452976714","title":"单抗概念盘中拉升，百奥泰涨4.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452976714","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452976714?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:36","pubTimestamp":1721180198,"startTime":"0","endTime":"0","summary":"07月17日，单抗概念盘中拉升，截至09点36分，单抗概念整体指数上涨0.59%，报1650.430点。从个股上来看，该概念的成分股中，百奥泰涨4.24%，百克生物、君实生物-U、百济神州-U涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-2692.93万，其中百克生物受到资金热捧，主力净流入291.45万；拉长时间线来看，该板块近20日主力资金净流入-15.36亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170936389681d53b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407170936389681d53b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688276","688177","BK0239"],"gpt_icon":0},{"id":"2452760929","title":"百奥泰大幅上涨 获北向资金减持2.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452760929","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452760929?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:35","pubTimestamp":1721180118,"startTime":"0","endTime":"0","summary":"07月17日，百奥泰股价大幅上涨，截至09点35分，百奥泰上涨5.12%，报21.55元/股，成交813万元，换手率0.09%，振幅4.63%。资金动向截止发稿，百奥泰获得主力净流出86万元。北向资金方面，百奥泰07月16日获得北向资金减持2.16万股，截至07月16日，北向资金当前共持有百奥泰297.65万股，市值6414万元，持股占流通股比为0.71%。最新财报显示，今年一季报，百奥泰实现营业收入1.62亿元，同比增长4.30%，净利润为-1.19亿元，同比增长16.57%，基本每股收益为-0.29元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717093730aefa057a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717093730aefa057a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2451954420","title":"百奥泰07月16日主力资金流入235万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2451954420","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451954420?lang=zh_cn&edition=full","pubTime":"2024-07-16 15:19","pubTimestamp":1721114346,"startTime":"0","endTime":"0","summary":"07月16日, 百奥泰股价跌0.05%，报收20.50元，成交金额3792万元，换手率0.45%，振幅3.75%，量比0.81。百奥泰今日主力资金净流入235万元，连续5日净流入，上一交易日主力净流入161万元，今日环比增加45.96%。该股近5个交易日上涨3.33%，主力资金累计净流入1375万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出306万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071615320095c5de90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071615320095c5de90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2451881549","title":"百奥泰（688177）7月15日主力资金净买入139.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451881549","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451881549?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:23","pubTimestamp":1721089400,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月15日收盘，百奥泰报收于20.51元，下跌3.66%，换手率0.46%，成交量1.92万手，成交额3954.01万元。近5日资金流向一览见下表：百奥泰融资融券信息显示，融资方面，当日融资买入152.4万元，融资偿还269.37万元，融资净偿还116.96万元。百奥泰主营业务：创新药和生物类似药的研发、生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600013258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2450737435","title":"百奥泰07月12日主力资金流入521万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450737435","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450737435?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:17","pubTimestamp":1720768675,"startTime":"0","endTime":"0","summary":"07月12日, 百奥泰股价涨1.19%，报收21.29元，成交金额4830万元，换手率0.55%，振幅3.99%，量比0.86。百奥泰今日主力资金净流入521万元，连续3日净流入，上一交易日主力净流入244万元，今日环比增加113.52%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为54.55%，平均涨幅为3.27%。该股近5个交易日下跌0.47%，主力资金累计净流出58万元；近20日主力资金累计净流出687万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121523189f3a1472&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121523189f3a1472&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2450380405","title":"7月11日百奥泰涨5.04%，富国医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450380405","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450380405?lang=zh_cn&edition=full","pubTime":"2024-07-11 16:16","pubTimestamp":1720685792,"startTime":"0","endTime":"0","summary":"证券之星消息，7月11日百奥泰涨5.04%，收盘报21.04元，换手率0.55%，成交量2.27万手，成交额4720.29万元。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为富国医疗保健行业混合A。孙笑悦在任的基金产品包括:富国医药成长30股票，管理时间为2020年4月9日至今，期间收益率为-30.08%；富国医疗产业混合发起式A，管理时间为2024年5月21日至今，期间收益率为nan%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100030012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2450380119","title":"百奥泰涨5.04%，太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2450380119","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450380119?lang=zh_cn&edition=full","pubTime":"2024-07-11 16:16","pubTimestamp":1720685784,"startTime":"0","endTime":"0","summary":"今日百奥泰涨5.04%，收盘报21.04元。2024年4月16日，太平洋研究员谭紫媚,张懿发布了对百奥泰的研报《百奥泰：生物类似药高速增长，创新药管线顺利推进》，该研报对百奥泰给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为32.65%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中信证券的王凯旋、陈竹、韩世通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100030010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","688177"],"gpt_icon":0},{"id":"2450087031","title":"百奥泰大幅上涨 获北向资金增持2.00万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450087031","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450087031?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:11","pubTimestamp":1720663898,"startTime":"0","endTime":"0","summary":"07月11日，百奥泰股价大幅上涨，截至10点11分，百奥泰上涨5.04%，报21.04元/股，成交1891万元，换手率0.22%。资金动向截止发稿，百奥泰获得主力净流入159万元，其中超大单流入94万元，大单流入64万元。北向资金方面，百奥泰07月10日获得北向资金增持2.00万股，截至07月10日，北向资金当前共持有百奥泰294.96万股，市值6205万元，持股占流通股比为0.71%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711101351aef91b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711101351aef91b0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2450885728","title":"百奥泰（688177）7月9日主力资金净卖出926.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450885728","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450885728?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:22","pubTimestamp":1720570935,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月9日收盘，百奥泰报收于19.84元，下跌1.39%，换手率0.77%，成交量3.2万手，成交额6364.78万元。近5日资金流向一览见下表：百奥泰融资融券信息显示，融资方面，当日融资买入273.67万元，融资偿还211.88万元，融资净买入61.79万元。百奥泰主营业务：创新药和生物类似药的研发、生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000013364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688177","BK0239"],"gpt_icon":0},{"id":"2450096893","title":"百奥泰07月09日遭主力抛售803万元 环比增加243.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450096893","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450096893?lang=zh_cn&edition=full","pubTime":"2024-07-09 15:19","pubTimestamp":1720509559,"startTime":"0","endTime":"0","summary":"07月09日, 百奥泰股价跌1.39%，报收19.84元，成交金额6364万元，换手率0.77%，振幅3.73%，量比1.41。百奥泰今日主力资金净流出803万元，连续6日净流出，上一交易日主力净流出234万元，今日环比增加243.16%。|07月09日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|蓝箭电子|10.81%|#|英力股份|7.33%|#|智立方|7.09%|#|捷邦科技|6.54%|#|天迈科技|5.85%|#|凯旺科技|5.83%|#|神宇股份|5.47%|#|宗申动力|3.36%|#|惠威科技|3.10%|#|亚通股份|2.95%|百奥泰所在的生物制品行业，今日主力净流出1679万元，行业排名24/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709153238959594e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709153238959594e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688177"],"gpt_icon":0},{"id":"2449715723","title":"7月8日百奥泰跌5.94%，富国医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449715723","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449715723?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:11","pubTimestamp":1720426312,"startTime":"0","endTime":"0","summary":"证券之星消息，7月8日百奥泰跌5.94%创60日新低，收盘报20.12元，换手率0.78%，成交量3.25万手，成交额6629.44万元。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为富国医疗保健行业混合A。孙笑悦在任的基金产品包括:富国医药成长30股票，管理时间为2020年4月9日至今，期间收益率为-27.47%；富国医疗产业混合发起式A，管理时间为2024年5月21日至今，期间收益率为nan%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800020154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688177"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-02-21","address":"广东省广州市黄埔区高新技术产业开发区科学城开源大道11号A6栋第五层","stockEarnings":[{"period":"1week","weight":0.058},{"period":"1month","weight":-0.0368},{"period":"3month","weight":-0.2689},{"period":"6month","weight":-0.3964},{"period":"1year","weight":-0.2478},{"period":"ytd","weight":-0.4738}],"companyName":"百奥泰生物制药股份有限公司","boardCode":"AI0027","perCapita":"56322股","boardName":"医药制造业","registeredCapital":"41408万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 百奥泰生物制药股份有限公司的主营业务是药物的研发、生产和销售。公司的主要产品是创新药和生物类似药，用于治疗肿瘤、自身免疫性疾病、心血管疾病以及其它危及人类生命或健康的重大疾病。","serverTime":1721718982900,"listedPrice":32.76,"stockholders":"7352人(较上一季度减少0.97%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥泰(688177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥泰(688177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥泰,688177,百奥泰股票,百奥泰股票老虎,百奥泰股票老虎国际,百奥泰行情,百奥泰股票行情,百奥泰股价,百奥泰股市,百奥泰股票价格,百奥泰股票交易,百奥泰股票购买,百奥泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥泰(688177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥泰(688177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}